Interaction between amphiphilic peptides and phospholipid membranes

Current Opinion in Colloid and Interface Science

Volumn 15, Issue 6, 2010, Pages 467-478

  Strömstedt, Adam A A ^a   Ringstad, Lovisa ^a   Schmidtchen, Artur ^b   Malmsten, Martin ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

AMP; Antimicrobial peptide; Bacteria; Liposome; Membrane

Indexed keywords

AMP; AMPHIPHILICS; ANTIMICROBIAL PEPTIDE; ILLUSTRATIVE EXAMPLES; MEMBRANE CHARGE; MEMBRANE COMPOSITION; MEMBRANE STABILITY; PEPTIDE ADSORPTION; PEPTIDE LENGTH; PEPTIDE-MEMBRANE INTERACTIONS; PHOSPHOLIPID MEMBRANE; POLAR HEADGROUPS; SECONDARY STRUCTURES;

ADSORPTION; BACTERIOLOGY; DRUG INTERACTIONS; MEMBRANES; MICROORGANISMS; PHOSPHOLIPIDS; POLYPEPTIDES;

PEPTIDES;

ANTIINFECTIVE AGENT; ARABINOSE DERIVATIVE; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHOLESTEROL; DEXTRO ALANINE; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; POLYPEPTIDE ANTIBIOTIC AGENT; STEROL;

ADSORPTION; BACTERICIDAL ACTIVITY; BACTERIOLYSIS; CARBOXY TERMINAL SEQUENCE; HYDROPHOBICITY; MEMBRANE DAMAGE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

EID: 77957960555     PISSN: 13590294     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cocis.2010.05.006     Document Type: Review

References (74)

1. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat Rev Micro 2005, 3:238-250.
2. The Antimicrobial Peptide Database. 2010. http://aps.unmc.edu/AP/.
3. Cornut I., Büttner K., Dasseaux J.-L., Dufourcq J. The amphipathic a-helix concept: application to the de novo design of ideally amphipathic Leu, Lys peptides with hemolytic activity higher than melittin. FEBS Lett 1994, 349:29-33.
4. Lohner K., Sevcsik E., Pasb G. Liposome-based biomembrane mimetic systems: implications for peptide-lipid interactions. Advances in planar lipid bilayers and liposomes 2008, Elsevier, Amsterdam. A. Leitmannova-Liu (Ed.).
5. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66:236-248.
6. Qian S., Wang W., Wang L., Huang H.W. Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. Biophys J 2008, 94:3512-3522.
7. Huang H.W. Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys J 2009, 96:3263-3272.
8. Huang H.W. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim Biophys Acta 2006, 1758:1292-1302.
9. Melo M.N., Ferre R., Castanho M.A. Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations. Nat Rev Micro 2009, 7:245-250.
10. Pokorny A., Almeida P.F.F. Kinetics of dye efflux and lipid flip-flop induced by Δ-lysin in phospholipid vesicles and the mechanism of graded release by amphipathic, α-helical peptides. Biochemistry 2004, 43:8846-8857.
11. Mecke A., Lee D.-K., Ramamoorthy A., Orr B.G., Banaszak Holl M.M. Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers. Biophys J 2005, 89:4043-4050.
12. Angelova A., Ionov R., Koch M.H.J., Rapp G. Interaction of the peptide antibiotic alamethicin with bilayer- and non-bilayer-forming lipids: influence of increasing alamethicin concentration on the lipids supramolecular structures. Arch Biochem Biophys 2000, 378:93-106.
13. El Jastimi R., Lafleur M. Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamines. Biochim Biophys Acta 1999, 1418:97-105.
14. Epand R.M., Epand R.F. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta 2009, 1788:289-294.
15. Cardin A.D., Weintraub H.J.R. Molecular modeling of protein-glucosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32.
16. Andersson E., Rydengård V., Sonesson A., Mörgelin M., Björck L., Schmidtchen A. Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004, 271:1219-1226.
17. Ringstad L., Schmidtchen A., Malmsten M. Effect of peptide length on the interaction between consensus peptides and DOPC/DOPA bilayers. Langmuir 2006, 22:5042-5050.
18. Papo N., Shai Y. Exploring peptide membrane interactions using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptides. Biochemistry 2003, 42:458-466.
19. Nielsen S.B., Otzen D.E. Impact of the antimicrobial peptide Novicidin on membrane structure integrity. J Colloid Interface Sci 2010, 345:248-256.
20. Chenal A., Prongidi-Fix L., Perier A., Aisenbrey C., Vernier G., Lambotte S., Fragneto G., Bechinger B., Gillet D., Forge V., Ferrand M. J Mol Biol 2009, 391:872-883.
21. Ringstad L., Kacprzyk L., Schmidtchen A., Malmsten M. Effects of topology, length, and charge on the activity of a kininogen-derived peptide on lipid membranes and bacteria. Biochim Biophys Acta 2007, 1768:715-727.
22. Deslouches B., Phadke S.M., Lazarevic V., Cascio M., Islam K., Montelaro R.C., et al. novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob Agents Chemother 2005, 49:316-322.
23. Durr U.H., Sudheendra U.S., Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 2006, 1758:1408-1425.
24. Nizet V. Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 2006, 8:11-26.
25. Nordahl E., Rydengård V., Nyberg P., Nitsche D., Mörgelin M., Malmsten M., et al. Activation of the complement system generates antibacterial peptides. Proc Natl Acad Sci U S A 2004, 101:16879-16884.
26. Pasupuleti M., Walse B., Svensson B., Malmsten M., Schmidtchen A. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach. Biochemistry 2008, 47:9057-9070.
27. Andersson Nordahl E., Rydengård V., Mörgelin M., Schmidtchen A. Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 2005, 41:34832-34839.
28. Frick I.-M., Åkesson P., Herwald H., Mörgelin M., Malmsten M., Nägler D.K., Björck L. The contact system - a novel branch of innate immunity generating antibacterial peptides. EMBO J 2006, 25:5569-5578.
29. Sigurdadottir T., Andersson P., Davoudi M., Malmsten M., Schmidtchen A., Bodelsson M. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37. Antimicrob Agents Chemother 2006, 50:2983-2989.
30. Ringstad L., Andersson Nordahl E., Schmidtchen A., Malmsten M. Composition effect on peptide interaction with lipids and bacteria: variants of C3a peptide CNY21. Biophys J 2007, 92:87-98.
31. Ringstad L., Protopapa E., Lindholm-Sethson B., Schmidtchen A., Nelson A., Malmsten M. An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers. Langmuir 2008, 24:208-216.
32. Dathe M., Wieprecht T., Nikolenko H., Handel L., Maloy W.L., MacDonald D.L., et al. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett 1997, 403:208-212.
33. Jenssen H., Lejon T., Hilpert K., Fjell C.D., Cherkasov A., Hancock R.E. Evaluating different descriptors for model design of antimicrobial peptides with enhanced activity toward P. aeruginosa. Biol Drug Des 2007, 70:134-142.
34. Jerala R. Synthetic lipopeptides: a novel class of anti-infectives. Expert Opin Investig Drugs 2007, 16:1159-1169.
35. Avrahami D., Shai Y. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity. Biochemistry 2002, 41:2254-2263.
36. Schmidtchen A., Pasupuleti M., Mörgelin M., Davoudi M., Alenfall J., Chalupka A., et al. Boosting antimicrobial peptides by hydrophobic oligopeptide end-tags. J Biol Chem 2009, 284:17584-17594.
37. Pasupuleti M., Schmidtchen A., Chalupka A., Ringstad L., Malmsten M. End-tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate bacterial killing. PLoS ONE 2009, 4(e5285):1-9.
38. Pasupuleti M., Chalupka A., Mörgelin M., Schmidtchen A., Malmsten M. Tryptophan end-tagging of antimicrobial peptides for increased potency against Pseudomonas aeruginosa. Biochim Biophys Acta 2009, 1790:800-808.
39. Haney E.F., Lau F., Vogel H.J. Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim Biophys Acta 2007, 1768:2355-2364.
40. Li X., Li Y., Peterkofsky A., Wang G. NMR studies of aurein 1.2 analogs. Biochim Biophys Acta 2006, 1758:1203-1214.
41. Mouritsen O.G., Zuckermann M.J. What's so special about cholesterol?. Lipids 2004, 39:1101-1113.
42. Strömstedt A.A., Pasupuleti M., Schmidtchen A., Malmsten M. Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochim Biophys Acta 2009, 1788:1916-1923.
43. Kacprzyk L., Rydengård V., Mörgelin M., Davoudi M., Pasupuleti M., Malmsten M., et al. Antimicrobial activity of histidine-rich peptides is dependent on acidic conditions. Biochim Biophys Acta 2007, 1768:2667-2680.
44. Makovitzki A., Shai Y. pH-Dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 2005, 44:9775-9784.
45. Giangaspero A., Sandri L., Tossi A. Amphipatic α helical antimicrobial peptides: a systematic study of the effects of structural and physical properties on biological activity. Eur J Biochem 2001, 268:5589-5600.
46. Malmsten M., Burns N., Veide A. Electrostatic and hydrophobic effects of oligopeptide insertions on protein adsorption. J Colloid Interface Sci 1998, 204:104-111.
47. Esson J.M., Ramamurthy N., Meyerhoff M.E. Polyelectrolyte-surfactant complexes: an aqueous titration method to model ion-pairing with polymeric membranes of polyion-sensitive electrodes. Anal Chim Acta 2000, 404:83-94.
48. Schug K.A., Lindner W. Noncovalent binding between guanidinium and anionic groups: focus on biological and synthetic-based arginine/guanidinium interactions with phosph[on]ate and sulf[[on]ate residues. Chem Rev 2005, 105:67-113.
49. Bysell H., Malmsten M. Interactions between homopolypeptides and lightly cross-linked microgels. Langmuir 2009, 25:522-528.
50. Sakai N., Matile S. Anion-mediated transfer of polyarginine across liquid and bilayer membranes. J Am Chem Soc 2003, 125:14348-14356.
51. Rothbard J.B., Jessop T.C., Wender P.A. Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv Drug Deliv Rev 2005, 57:495-504.
52. Patel A., Cosgrove T., Semlyen J.A. Studies of cyclic and linear poly(dimethylsiloxanes): 30. Adsorption studies on silica in solution. Polymer 1991, 32:1313-1317.
53. Krishnakumari V., Sharadadevi A., Sitaram N., Nagaraj R. Consequences of introducing a disulfide bond into an antibacterial and hemolytic peptide. J Pept Res 1999, 54:528-535.
54. Unger T., Oren Z., Shai Y. The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implications to their mode of action. Biochemistry 2001, 40:6388-6397.
55. Ramamoorthy A., Thennarasu S., Tan A., Gottipati K., Sreekumar S., Heyl D.L., et al. Deletion of all cysteines in Tachyplesin I abolishes hemolytic activity and retains antimicrobial activity and lipopolysaccharide selective binding. Biochemistry 2006, 45:6529-6540.
56. Tossi A., Sandri L., Giangaspero A. Amphipathic, α-helical antimicrobial peptides. Biopolymers 2000, 55:4-30.
57. Sieprawska-Lupa M., Mydel P., Krawczyk K., Wojcik K., Puklo M., Lupa B., et al. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob Agents Chemother 2004, 48:4673-4679.
58. Ringstad L., Schmidtchen A., Malmsten M. Effects of single amino acid substitutions on peptide interaction with lipid membranes and bacteria - variants of GKE21, an internal sequence from human LL-37. Colloids Surf A 2010, 354:65-71.
59. Strömstedt A.A., Pasupuleti M., Schmidtchen A., Malmsten M. Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 2009, 53:593-602.
60. Shalev D.E., Mor A., Kustanovich I. Structural consequences of carboxyamidation of dermaseptin S3. Biochemistry 2002, 41:7312-7317.
61. Hong S.Y., Oh J.E., Lee K.H. Effect of d-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol 1999, 58:1775-1780.
62. Andrushchenko V.V., Vogel H.J., Prenner E.J. Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry. Biochim Biophys Acta 2007, 1768:2447-2458.
63. Zelezetsky I., Pacor S., Pag U., Papo N., Shai Y., Sahl H.G., et al. Controlled alteration of the shape and conformational stability of α-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem J 2005, 390:177-188.
64. Henriksen J., Rowat A.C., Brief E., Hsueh Y.W., Thewalt J.L., Zuckermann M.J., et al. Universal behavior of membranes with sterols. Biophys J 2006, 90:1639-1649.
65. Lugtenberg E.J.J., Peters R. Distribution of lipids in cytoplasmic and outer membranes of Escerichia coli K12. Biochim Biophys Acta 1976, 441:38-47.
66. Haest C.W., de Gier J., den Kamp J.A., Bartels P., van Deenen L.L. Changes in permeability of Staphylococcus aureus and derived liposomes with varying lipid composition. Biochim Biophys Acta 1972, 255:720-733.
67. Papareddy P., Rydengård V., Pasupuleti M., Walse B., Mörgelin M., Chalupka A., Malmsten M., Schmidtchen A. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathogens 2010, 6(4):e1000857. 1-15.
68. Rydengård V., Shannon O., Lundqvist K., Kacprzyk L., Chalupka A., Olsson A.-K., et al. Histidine-rich glycoprotein protects from systemic Candida infection. PLoS Pathog 2008, 4(e1000116):1-11.
69. Malmsten M., Davoudi M., Schmidtchen A. Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Matrix Biol 2006, 25:294-300.
70. Malmsten M., Davoudi M., Walse B., Rydengård V., Pasupuleti M., Mörgelin M., et al. Antimicrobial peptides derived from growth factors. Growth Factors 2007, 25:60-70.
71. Epand R.F., Mishra V.K., Palgunashari M.N., Anantharamaiah G.M., Epand R.M. Antiinflammatory peptides grab on to the whiskers of atherogenic oxidized lipids. Biochim Biophys Acta 2009, 1788:1967-1975.
72. Oreopoulos J., Epand R.F., Epand R.M., Yip C.M. Peptide-induced domain formation in supported lipid bilayers: direct evidence by combined atomic force and polarized total internal reflection fluorescence microscopy. Biophys J 2010, 98:815-823.
73. Raghuraman H., Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci Rep 2007, 27:189-223.
74. Strömstedt A.A., Wessman P., Ringstad L., Edwards K., Malmsten M. Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. J Colloid Interface Sci 2007, 311:56-69.